Therapeutic Nuclear Medicines Sales Market - Forecast(2024 - 2030)

Report Code: HCR 90937 Report Format: PDF + Excel

Therapeutic Nuclear Medicines Sales Market Overview

Therapeutic Nuclear Medicines Sales Market size is estimated at $1.6 billion in 2020, projected to grow at a CAGR of 7.3% during the forecast period 2021-2026. Therapeutic Nuclear Medicine is a pharmaceutical formulation containing radioactive materials. Cancer, metastatic bone tumors, and other disorders are treated with therapeutic nuclear medicines. Therapeutic nuclear drugs contain radioactive material that can destroy cancerous tissue, shrink tumors, and alleviate pain. Alpha Emitters, Beta Emitters and Brachytherapy Isotopes are the various types of therapeutic nuclear medicines. 

The rising incidence and prevalence of cancer and cardiac disorders, as well as measures to close the demand-supply gap for Mo-99 and radiopharmaceuticals are driving growth in the therapeutic nuclear medicines sales industry. Thyroid-related disorders like hyperthyroidism, respiratory diseases, bone diseases, and neurological diseases neuroblastoma are among the conditions for which research and studies are performed. 

For instance, French researchers published research in July 2019 demonstrating the use of hafnium oxide nanoparticle NBTXR3 as a radio enhancer to boost radioimmunotherapy response for soft-tissue sarcoma Theragnostic which is expected to boost the overall market demand for Therapeutic Nuclear Medicines Sales Industry. Government policies and funding for the development of new techniques are expected to push therapeutic nuclear medicine.

For example, in January 2019, the European Fund for Regional Development (EFRO) and the Kansen voor West organisation funded NRG to FIELD-LAB, which will develop new nuclear medicines for cancer treatment.

Therapeutic Nuclear Medicines Sales Market Report Coverage

The report: “Therapeutic Nuclear Medicines Sales Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Therapeutic Nuclear Medicines Sales Market.

By Type: Alpha Emitters, Beta Emitters and Brachytherapy Isotopes.
By Application: Cardiology, Bone Scans, Pulmonary Scans, Oncology, Neurology, Thyroid Indications, Bone Metastasis and Others.
By End User: Hospitals, Ambulatory Surgical Centres and Cancer Research Institutes.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America) and RoW (Middle East and Africa).

Key Takeaways

  • The growing need for early and reliable diagnosis, as well as the increasing demand for better medical solutions around the globe, is expected to drive demand for Therapeutic Nuclear Medicines Sales Industry.
  • Geographically, North America Therapeutic Nuclear Medicines Sales Market held the largest revenue share of 37% in 2020 owing to the involvement of potential players who are developing innovative products, high investments in R&D and support of government towards the use of medical isotopes investments in healthcare.
  • The Therapeutic Nuclear Medicines Sales Industry is being driven by the growing geriatric population and increased understanding of nuclear medicines and molecular imaging.
  • Furthermore, radiopharmaceuticals are widely used in molecular imaging, a method in which molecules are used as biomarkers for complex molecular processes that decide the initiation and/or progression of disease driving the demand for Therapeutic Nuclear Medicines Sales Industry.

Therapeutic Nuclear Medicines Sales Market: Market Share (%) by Region, 2020

 For More Details on This Report - Request for Sample

Therapeutic Nuclear Medicines Sales Market Segment Analysis - By Type

Based on Type, Therapeutic Nuclear Medicines Sales Market is segmented into Alpha Emitters, Beta Emitters and Brachytherapy Isotopes. Beta Emitters accounted for the largest revenue market share in 2020 owing to less damage to surrounding cells, low energy levels, and travel long distance. Furthermore, I-131, Y-90, SM-153, and Re-186 are the most widely used beta emitting radioisotopes. The cost of treating an untreated wound is much greater than the cost of treating a common disease. 

Owing to the disease's high prevalence, there will be many opportunities for companies in the industry to expand. It also serves as a simpler and safer alternative to X-Rays and other external radiation imaging devices for patients, as opposed to X-Rays and other radioimmunotherapy external radiation imaging devices aids to Therapeutic Nuclear Medicines Sales Industry expansion. 

Brachytherapy Isotopes segment is anticipated to grow with the fastest CAGR of 7.9% in the forecast period 2021-2026. This is attributed to the rise in the increasing global acceptance of hybrid imaging, increasing levels of funds for advanced technology advancement, rising application of radiopharmaceuticals, and adoption of various treatment and diagnosis are some of the factors that are anticipated boost the growth of the brachytherapy isotopes.

Therapeutic Nuclear Medicines Sales Market Segment Analysis – By Application

Based on Application, Therapeutic Nuclear Medicines Sales Market is segmented into Cardiology, Bone Scans, Pulmonary Scans, Oncology, Neurology, Thyroid Indications, Bone Metastasis and Others. Thyroid Indications accounted for the largest revenue market share in 2020 as hypothyroidism is becoming more common, and people are becoming more conscious of it, which is fueling market development. Various companies are working with government agencies to raise disease control awareness, which is expected to increase the acceptance of drugs for thyroid gland disorders. 

It currently affects 200 million people worldwide, with half of the population in most countries remaining undiagnosed. Women and the elderly are more likely to develop this disorder. According to the Thyroid Foundation of Canada's 2015 statistics, congenital hypothyroidism affects one out of every 1700 children in Canada. This depicts the potential for therapeutic drug demand in the coming years, thereby, driving the Therapeutic Nuclear Medicines Sales Industry growth. Cardiology segment is anticipated to grow with the fastest CAGR of 7.6% during the forecast period 2021-2026 owing to the low cost of techniques like radioimmunotherapy and high acceptance rate. As a result, major players are concentrating their efforts on developing new diagnostic methods to tackle cardiovascular diseases.

Therapeutic Nuclear Medicines Sales Market Segment Analysis - By Geography

Based on Geography, North America Therapeutic Nuclear Medicines Sales Market accounted for the 37% revenue share in 2020 owing to the existence of streamlined healthcare facilities, higher levels of individual understanding, and a wide range of treatment choices like radiopharmaceutical, alpha emitters & beta emitters to choose from are all factors that contribute to its large revenue share. Pharmaceutical companies and government organizations are forming strategic alliances in the region, especially to develop generic drugs and raise awareness among healthcare professionals. 

As a result, the North American market is extremely lucrative. For instance, Genzyme will provide customized solutions for the treatment of thyroid gland disorders in collaboration with Veracyte Inc. aiding growth towards the Therapeutic Nuclear Medicines Sales Industry. Asia-Pacific is predicted to be the fastest growing region during the forecast period 2021- 2026 owing towards the increasing geriatric population and increased awareness of nuclear medicines and molecular imaging. This area is also concentrating on the manufacture of radiopharmaceuticals for the diagnosis and treatment of a variety of diseases like metastatic bone pain, radionuclide therapy. 

In August 2018, the National Nuclear Agency of Indonesia (BATAN) collaborated with the International Atomic Energy Agency (IAEA) to create new radiopharmaceuticals (99mTc-ethambutol) for tuberculosis diagnosis driving the market growth.

Therapeutic Nuclear Medicines Sales Market - Drivers

The Use Of Radiopharmaceuticals For Therapeutic Purposes Is Gaining Popularity:

Radiopharmaceuticals are used in both diagnostic and therapeutic procedures. Therapeutic nuclear medicines currently account for 12-13 percent of global radiopharmaceutical revenue; however, due to the positive results of Xofigo for the treatment of prostate cancer, monoclonal antibodies and the launch of Iodine-131 for the treatment of hypothyroidism and thyroid cancer, therapeutic nuclear medicines are expected to account for 60-65 percent of global radiopharmaceutical revenue by 2030. Furthermore, for the sale of their drugs, the leading radiopharmaceutical manufacturers are partnering with hospitals and cancer research institutes, aiding growth towards the Therapeutic Nuclear Medicines Sales Market.

Therapeutic Nuclear Medicines Sales Market Challenges

Stringent Regulatory Guidelines:

Strict regulatory requirements and a shortage of standardization resources in some developed and developing countries are two major factors that are expected to hinder Therapeutic Nuclear Medicines Sales market growth. According to the Nuclear Regulatory Commission, nearly 6,000 licenses for the use of radioactive materials are in place, with violations resulting in disciplinary measures such as license revocation. The FDA's strict regulatory guidelines for the approval and development of radiopharmaceuticals are likely to stifle the therapeutic nuclear medicine market's revenue growth. The market's growth is being hampered by high costs, a scarcity of isotopes, and the possibility of traditional/alternative diagnostic procedures.

Therapeutic Nuclear Medicines Sales Market - Landscape

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Therapeutic Nuclear Medicines Sales Market.  Therapeutic Nuclear Medicines Sales Market top 10 companies are Cardinal Health, Eckert & Ziegler, Curium Pharma, International Isotopes Idaho, Inc., Medi-Radiopharma Co., Ltd., Novartis AG, Orano, Isoray Inc., Jubilant Pharma, Progenics Pharmaceuticals and Theragenics Corporation.

Acquisitions/Product Launches:

  • In June, 2020, Lantheus Holdings, Inc., a global leader in the growth, manufacture, and commercialization of advanced diagnostic imaging agents and devices, has merged with Progenics Pharmaceuticals, an oncology company developing innovative medicines and artificial intelligence to detect, battle, and track cancer. The company's growth will be boosted as a result of this merger.

Related Reports-

Nuclear Medicine Equipment Market - Forecast(2021 - 2026)

Report Code: HCR 0572

North American Nuclear Medicine/Radiopharmaceuticals Market - Forecast(2021 - 2026)

Report Code: HCR 0472

 For more Lifesciences and Healthcare Market reports, please click here

1. Therapeutic Nuclear Medicines Sales Market - Overview
    1.1 Definitions and Scope
2. Therapeutic Nuclear Medicines Sales Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Type
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Therapeutic Nuclear Medicines Sales Market - Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Therapeutic Nuclear Medicines Sales Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Therapeutic Nuclear Medicines Sales Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Therapeutic Nuclear Medicines Sales Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Therapeutic Nuclear Medicines Sales Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Therapeutic Nuclear Medicines Sales Market – By Type (Market Size –$Million/$Billion)
    8.1 Alpha Emitters
    8.2 Beta Emitters
    8.3 Brachytherapy Isotopes
9. Therapeutic Nuclear Medicines Sales Market – By Application (Market Size –$Million/$Billion)
    9.1 Cardiology
    9.2 Bone Scans
    9.3 Pulmonary Scans
    9.4 Oncology
    9.5 Neurology
    9.6 Thyroid Indications
    9.7 Bone Metastasis
    9.8 Others
10. Therapeutic Nuclear Medicines Sales Market – By End User (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Ambulatory Surgical Centers
    10.3 Cancer Research Institutes
11. Therapeutic Nuclear Medicines Sales Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Therapeutic Nuclear Medicines Sales Market - Entropy
13. Therapeutic Nuclear Medicines Sales Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Therapeutic Nuclear Medicines Sales Market – Key Company List by Country Premium Premium
15. Therapeutic Nuclear Medicines Sales Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competition Analysis Market 2023-2030 ($M)
1.1 Competitors Deep Dive Market 2023-2030 ($M) - Global Industry Research
1.1.1 Bayer AG Market 2023-2030 ($M)
1.1.2 Novartis AG Market 2023-2030 ($M)
1.1.3 GE Healthcare Market 2023-2030 ($M)
1.1.4 Curium Pharmaceuticals Market 2023-2030 ($M)
1.1.5 Jubilant DraxImage Market 2023-2030 ($M)
1.1.6 Spectrum Pharmaceuticals Market 2023-2030 ($M)
1.1.7 Progenics Pharmaceuticals, Inc. Market 2023-2030 ($M)
1.1.8 ANSTO Market 2023-2030 ($M)
1.1.9 Lantheus Medical Imaging, Inc. Market 2023-2030 ($M)
1.1.10 Eckert Ziegler Market 2023-2030 ($M)
1.1.11 International Isotopes Inc. Market 2023-2030 ($M)
1.1.12 SHINE Medical Technologies Inc. Market 2023-2030 ($M)
2.Global Therapeutic Nuclear Medicine Market Analysis and Forecast , By Radionuclide Type Market 2023-2030 ($M)
2.1 By Radionuclide Type, Market 2023-2030 ($M) - Global Industry Research
2.1.1 Radium-223 Market 2023-2030 ($M)
2.1.2 Iodine-131 Market 2023-2030 ($M)
2.1.3 Leutitium-177 Market 2023-2030 ($M)
2.1.4 Yttrium-90 Market 2023-2030 ($M)
2.1.5 Samarium-153 Market 2023-2030 ($M)
2.1.6 Strontium-89 Market 2023-2030 ($M)
2.1.7 Rhenium-188 + Rhenium-186 Market 2023-2030 ($M)
2.1.8 Erbium-169 Market 2023-2030 ($M)
2.1.9 Phosphorus-32 Market 2023-2030 ($M)
2.2 By Radionuclide Type, Market 2023-2030 ($M) - Global Industry Research
3.Global Therapeutic Nuclear Medicine Market Analysis and Forecast , By Indication Market 2023-2030 ($M)
3.1 By Indication, Market 2023-2030 ($M) - Global Industry Research
3.1.1 Prostate Cancer Market 2023-2030 ($M)
3.1.2 Painful Bone Metastases Market 2023-2030 ($M)
3.1.3 Thyroid Cancer Market 2023-2030 ($M)
3.1.4 Neuroblastoma Market 2023-2030 ($M)
3.1.5 Synovitis Market 2023-2030 ($M)
3.1.6 Non-Hodgkins Lymphoma Market 2023-2030 ($M)
3.1.7 Hepatic Metastases Market 2023-2030 ($M)
3.1.8 Brain Tumour Market 2023-2030 ($M)
3.2 By Indication, Market 2023-2030 ($M) - Global Industry Research
4.Global Therapeutic Nuclear Medicine Market Analysis and Forecast , By End User Market 2023-2030 ($M)
4.1 By End User, Market 2023-2030 ($M) - Global Industry Research
4.1.1 Hospitals Market 2023-2030 ($M)
4.1.2 Ambulatory Surgical Centers Market 2023-2030 ($M)
4.1.3 Cancer Research Institutes Market 2023-2030 ($M)
4.2 By End User, Market 2023-2030 ($M) - Global Industry Research
5.Global Competition Analysis Market 2023-2030 (Volume/Units)
5.1 Competitors Deep Dive Market 2023-2030 (Volume/Units) - Global Industry Research
5.1.1 Bayer AG Market 2023-2030 (Volume/Units)
5.1.2 Novartis AG Market 2023-2030 (Volume/Units)
5.1.3 GE Healthcare Market 2023-2030 (Volume/Units)
5.1.4 Curium Pharmaceuticals Market 2023-2030 (Volume/Units)
5.1.5 Jubilant DraxImage Market 2023-2030 (Volume/Units)
5.1.6 Spectrum Pharmaceuticals Market 2023-2030 (Volume/Units)
5.1.7 Progenics Pharmaceuticals, Inc. Market 2023-2030 (Volume/Units)
5.1.8 ANSTO Market 2023-2030 (Volume/Units)
5.1.9 Lantheus Medical Imaging, Inc. Market 2023-2030 (Volume/Units)
5.1.10 Eckert Ziegler Market 2023-2030 (Volume/Units)
5.1.11 International Isotopes Inc. Market 2023-2030 (Volume/Units)
5.1.12 SHINE Medical Technologies Inc. Market 2023-2030 (Volume/Units)
6.Global Therapeutic Nuclear Medicine Market Analysis and Forecast , By Radionuclide Type Market 2023-2030 (Volume/Units)
6.1 By Radionuclide Type, Market 2023-2030 (Volume/Units) - Global Industry Research
6.1.1 Radium-223 Market 2023-2030 (Volume/Units)
6.1.2 Iodine-131 Market 2023-2030 (Volume/Units)
6.1.3 Leutitium-177 Market 2023-2030 (Volume/Units)
6.1.4 Yttrium-90 Market 2023-2030 (Volume/Units)
6.1.5 Samarium-153 Market 2023-2030 (Volume/Units)
6.1.6 Strontium-89 Market 2023-2030 (Volume/Units)
6.1.7 Rhenium-188 + Rhenium-186 Market 2023-2030 (Volume/Units)
6.1.8 Erbium-169 Market 2023-2030 (Volume/Units)
6.1.9 Phosphorus-32 Market 2023-2030 (Volume/Units)
6.2 By Radionuclide Type, Market 2023-2030 (Volume/Units) - Global Industry Research
7.Global Therapeutic Nuclear Medicine Market Analysis and Forecast , By Indication Market 2023-2030 (Volume/Units)
7.1 By Indication, Market 2023-2030 (Volume/Units) - Global Industry Research
7.1.1 Prostate Cancer Market 2023-2030 (Volume/Units)
7.1.2 Painful Bone Metastases Market 2023-2030 (Volume/Units)
7.1.3 Thyroid Cancer Market 2023-2030 (Volume/Units)
7.1.4 Neuroblastoma Market 2023-2030 (Volume/Units)
7.1.5 Synovitis Market 2023-2030 (Volume/Units)
7.1.6 Non-Hodgkins Lymphoma Market 2023-2030 (Volume/Units)
7.1.7 Hepatic Metastases Market 2023-2030 (Volume/Units)
7.1.8 Brain Tumour Market 2023-2030 (Volume/Units)
7.2 By Indication, Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Therapeutic Nuclear Medicine Market Analysis and Forecast , By End User Market 2023-2030 (Volume/Units)
8.1 By End User, Market 2023-2030 (Volume/Units) - Global Industry Research
8.1.1 Hospitals Market 2023-2030 (Volume/Units)
8.1.2 Ambulatory Surgical Centers Market 2023-2030 (Volume/Units)
8.1.3 Cancer Research Institutes Market 2023-2030 (Volume/Units)
8.2 By End User, Market 2023-2030 (Volume/Units) - Global Industry Research
9.North America Competition Analysis Market 2023-2030 ($M)
9.1 Competitors Deep Dive Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Bayer AG Market 2023-2030 ($M)
9.1.2 Novartis AG Market 2023-2030 ($M)
9.1.3 GE Healthcare Market 2023-2030 ($M)
9.1.4 Curium Pharmaceuticals Market 2023-2030 ($M)
9.1.5 Jubilant DraxImage Market 2023-2030 ($M)
9.1.6 Spectrum Pharmaceuticals Market 2023-2030 ($M)
9.1.7 Progenics Pharmaceuticals, Inc. Market 2023-2030 ($M)
9.1.8 ANSTO Market 2023-2030 ($M)
9.1.9 Lantheus Medical Imaging, Inc. Market 2023-2030 ($M)
9.1.10 Eckert Ziegler Market 2023-2030 ($M)
9.1.11 International Isotopes Inc. Market 2023-2030 ($M)
9.1.12 SHINE Medical Technologies Inc. Market 2023-2030 ($M)
10.North America Therapeutic Nuclear Medicine Market Analysis and Forecast , By Radionuclide Type Market 2023-2030 ($M)
10.1 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Radium-223 Market 2023-2030 ($M)
10.1.2 Iodine-131 Market 2023-2030 ($M)
10.1.3 Leutitium-177 Market 2023-2030 ($M)
10.1.4 Yttrium-90 Market 2023-2030 ($M)
10.1.5 Samarium-153 Market 2023-2030 ($M)
10.1.6 Strontium-89 Market 2023-2030 ($M)
10.1.7 Rhenium-188 + Rhenium-186 Market 2023-2030 ($M)
10.1.8 Erbium-169 Market 2023-2030 ($M)
10.1.9 Phosphorus-32 Market 2023-2030 ($M)
10.2 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
11.North America Therapeutic Nuclear Medicine Market Analysis and Forecast , By Indication Market 2023-2030 ($M)
11.1 By Indication, Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Prostate Cancer Market 2023-2030 ($M)
11.1.2 Painful Bone Metastases Market 2023-2030 ($M)
11.1.3 Thyroid Cancer Market 2023-2030 ($M)
11.1.4 Neuroblastoma Market 2023-2030 ($M)
11.1.5 Synovitis Market 2023-2030 ($M)
11.1.6 Non-Hodgkins Lymphoma Market 2023-2030 ($M)
11.1.7 Hepatic Metastases Market 2023-2030 ($M)
11.1.8 Brain Tumour Market 2023-2030 ($M)
11.2 By Indication, Market 2023-2030 ($M) - Regional Industry Research
12.North America Therapeutic Nuclear Medicine Market Analysis and Forecast , By End User Market 2023-2030 ($M)
12.1 By End User, Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Hospitals Market 2023-2030 ($M)
12.1.2 Ambulatory Surgical Centers Market 2023-2030 ($M)
12.1.3 Cancer Research Institutes Market 2023-2030 ($M)
12.2 By End User, Market 2023-2030 ($M) - Regional Industry Research
13.South America Competition Analysis Market 2023-2030 ($M)
13.1 Competitors Deep Dive Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Bayer AG Market 2023-2030 ($M)
13.1.2 Novartis AG Market 2023-2030 ($M)
13.1.3 GE Healthcare Market 2023-2030 ($M)
13.1.4 Curium Pharmaceuticals Market 2023-2030 ($M)
13.1.5 Jubilant DraxImage Market 2023-2030 ($M)
13.1.6 Spectrum Pharmaceuticals Market 2023-2030 ($M)
13.1.7 Progenics Pharmaceuticals, Inc. Market 2023-2030 ($M)
13.1.8 ANSTO Market 2023-2030 ($M)
13.1.9 Lantheus Medical Imaging, Inc. Market 2023-2030 ($M)
13.1.10 Eckert Ziegler Market 2023-2030 ($M)
13.1.11 International Isotopes Inc. Market 2023-2030 ($M)
13.1.12 SHINE Medical Technologies Inc. Market 2023-2030 ($M)
14.South America Therapeutic Nuclear Medicine Market Analysis and Forecast , By Radionuclide Type Market 2023-2030 ($M)
14.1 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Radium-223 Market 2023-2030 ($M)
14.1.2 Iodine-131 Market 2023-2030 ($M)
14.1.3 Leutitium-177 Market 2023-2030 ($M)
14.1.4 Yttrium-90 Market 2023-2030 ($M)
14.1.5 Samarium-153 Market 2023-2030 ($M)
14.1.6 Strontium-89 Market 2023-2030 ($M)
14.1.7 Rhenium-188 + Rhenium-186 Market 2023-2030 ($M)
14.1.8 Erbium-169 Market 2023-2030 ($M)
14.1.9 Phosphorus-32 Market 2023-2030 ($M)
14.2 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
15.South America Therapeutic Nuclear Medicine Market Analysis and Forecast , By Indication Market 2023-2030 ($M)
15.1 By Indication, Market 2023-2030 ($M) - Regional Industry Research
15.1.1 Prostate Cancer Market 2023-2030 ($M)
15.1.2 Painful Bone Metastases Market 2023-2030 ($M)
15.1.3 Thyroid Cancer Market 2023-2030 ($M)
15.1.4 Neuroblastoma Market 2023-2030 ($M)
15.1.5 Synovitis Market 2023-2030 ($M)
15.1.6 Non-Hodgkins Lymphoma Market 2023-2030 ($M)
15.1.7 Hepatic Metastases Market 2023-2030 ($M)
15.1.8 Brain Tumour Market 2023-2030 ($M)
15.2 By Indication, Market 2023-2030 ($M) - Regional Industry Research
16.South America Therapeutic Nuclear Medicine Market Analysis and Forecast , By End User Market 2023-2030 ($M)
16.1 By End User, Market 2023-2030 ($M) - Regional Industry Research
16.1.1 Hospitals Market 2023-2030 ($M)
16.1.2 Ambulatory Surgical Centers Market 2023-2030 ($M)
16.1.3 Cancer Research Institutes Market 2023-2030 ($M)
16.2 By End User, Market 2023-2030 ($M) - Regional Industry Research
17.Europe Competition Analysis Market 2023-2030 ($M)
17.1 Competitors Deep Dive Market 2023-2030 ($M) - Regional Industry Research
17.1.1 Bayer AG Market 2023-2030 ($M)
17.1.2 Novartis AG Market 2023-2030 ($M)
17.1.3 GE Healthcare Market 2023-2030 ($M)
17.1.4 Curium Pharmaceuticals Market 2023-2030 ($M)
17.1.5 Jubilant DraxImage Market 2023-2030 ($M)
17.1.6 Spectrum Pharmaceuticals Market 2023-2030 ($M)
17.1.7 Progenics Pharmaceuticals, Inc. Market 2023-2030 ($M)
17.1.8 ANSTO Market 2023-2030 ($M)
17.1.9 Lantheus Medical Imaging, Inc. Market 2023-2030 ($M)
17.1.10 Eckert Ziegler Market 2023-2030 ($M)
17.1.11 International Isotopes Inc. Market 2023-2030 ($M)
17.1.12 SHINE Medical Technologies Inc. Market 2023-2030 ($M)
18.Europe Therapeutic Nuclear Medicine Market Analysis and Forecast , By Radionuclide Type Market 2023-2030 ($M)
18.1 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
18.1.1 Radium-223 Market 2023-2030 ($M)
18.1.2 Iodine-131 Market 2023-2030 ($M)
18.1.3 Leutitium-177 Market 2023-2030 ($M)
18.1.4 Yttrium-90 Market 2023-2030 ($M)
18.1.5 Samarium-153 Market 2023-2030 ($M)
18.1.6 Strontium-89 Market 2023-2030 ($M)
18.1.7 Rhenium-188 + Rhenium-186 Market 2023-2030 ($M)
18.1.8 Erbium-169 Market 2023-2030 ($M)
18.1.9 Phosphorus-32 Market 2023-2030 ($M)
18.2 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
19.Europe Therapeutic Nuclear Medicine Market Analysis and Forecast , By Indication Market 2023-2030 ($M)
19.1 By Indication, Market 2023-2030 ($M) - Regional Industry Research
19.1.1 Prostate Cancer Market 2023-2030 ($M)
19.1.2 Painful Bone Metastases Market 2023-2030 ($M)
19.1.3 Thyroid Cancer Market 2023-2030 ($M)
19.1.4 Neuroblastoma Market 2023-2030 ($M)
19.1.5 Synovitis Market 2023-2030 ($M)
19.1.6 Non-Hodgkins Lymphoma Market 2023-2030 ($M)
19.1.7 Hepatic Metastases Market 2023-2030 ($M)
19.1.8 Brain Tumour Market 2023-2030 ($M)
19.2 By Indication, Market 2023-2030 ($M) - Regional Industry Research
20.Europe Therapeutic Nuclear Medicine Market Analysis and Forecast , By End User Market 2023-2030 ($M)
20.1 By End User, Market 2023-2030 ($M) - Regional Industry Research
20.1.1 Hospitals Market 2023-2030 ($M)
20.1.2 Ambulatory Surgical Centers Market 2023-2030 ($M)
20.1.3 Cancer Research Institutes Market 2023-2030 ($M)
20.2 By End User, Market 2023-2030 ($M) - Regional Industry Research
21.APAC Competition Analysis Market 2023-2030 ($M)
21.1 Competitors Deep Dive Market 2023-2030 ($M) - Regional Industry Research
21.1.1 Bayer AG Market 2023-2030 ($M)
21.1.2 Novartis AG Market 2023-2030 ($M)
21.1.3 GE Healthcare Market 2023-2030 ($M)
21.1.4 Curium Pharmaceuticals Market 2023-2030 ($M)
21.1.5 Jubilant DraxImage Market 2023-2030 ($M)
21.1.6 Spectrum Pharmaceuticals Market 2023-2030 ($M)
21.1.7 Progenics Pharmaceuticals, Inc. Market 2023-2030 ($M)
21.1.8 ANSTO Market 2023-2030 ($M)
21.1.9 Lantheus Medical Imaging, Inc. Market 2023-2030 ($M)
21.1.10 Eckert Ziegler Market 2023-2030 ($M)
21.1.11 International Isotopes Inc. Market 2023-2030 ($M)
21.1.12 SHINE Medical Technologies Inc. Market 2023-2030 ($M)
22.APAC Therapeutic Nuclear Medicine Market Analysis and Forecast , By Radionuclide Type Market 2023-2030 ($M)
22.1 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
22.1.1 Radium-223 Market 2023-2030 ($M)
22.1.2 Iodine-131 Market 2023-2030 ($M)
22.1.3 Leutitium-177 Market 2023-2030 ($M)
22.1.4 Yttrium-90 Market 2023-2030 ($M)
22.1.5 Samarium-153 Market 2023-2030 ($M)
22.1.6 Strontium-89 Market 2023-2030 ($M)
22.1.7 Rhenium-188 + Rhenium-186 Market 2023-2030 ($M)
22.1.8 Erbium-169 Market 2023-2030 ($M)
22.1.9 Phosphorus-32 Market 2023-2030 ($M)
22.2 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
23.APAC Therapeutic Nuclear Medicine Market Analysis and Forecast , By Indication Market 2023-2030 ($M)
23.1 By Indication, Market 2023-2030 ($M) - Regional Industry Research
23.1.1 Prostate Cancer Market 2023-2030 ($M)
23.1.2 Painful Bone Metastases Market 2023-2030 ($M)
23.1.3 Thyroid Cancer Market 2023-2030 ($M)
23.1.4 Neuroblastoma Market 2023-2030 ($M)
23.1.5 Synovitis Market 2023-2030 ($M)
23.1.6 Non-Hodgkins Lymphoma Market 2023-2030 ($M)
23.1.7 Hepatic Metastases Market 2023-2030 ($M)
23.1.8 Brain Tumour Market 2023-2030 ($M)
23.2 By Indication, Market 2023-2030 ($M) - Regional Industry Research
24.APAC Therapeutic Nuclear Medicine Market Analysis and Forecast , By End User Market 2023-2030 ($M)
24.1 By End User, Market 2023-2030 ($M) - Regional Industry Research
24.1.1 Hospitals Market 2023-2030 ($M)
24.1.2 Ambulatory Surgical Centers Market 2023-2030 ($M)
24.1.3 Cancer Research Institutes Market 2023-2030 ($M)
24.2 By End User, Market 2023-2030 ($M) - Regional Industry Research
25.MENA Competition Analysis Market 2023-2030 ($M)
25.1 Competitors Deep Dive Market 2023-2030 ($M) - Regional Industry Research
25.1.1 Bayer AG Market 2023-2030 ($M)
25.1.2 Novartis AG Market 2023-2030 ($M)
25.1.3 GE Healthcare Market 2023-2030 ($M)
25.1.4 Curium Pharmaceuticals Market 2023-2030 ($M)
25.1.5 Jubilant DraxImage Market 2023-2030 ($M)
25.1.6 Spectrum Pharmaceuticals Market 2023-2030 ($M)
25.1.7 Progenics Pharmaceuticals, Inc. Market 2023-2030 ($M)
25.1.8 ANSTO Market 2023-2030 ($M)
25.1.9 Lantheus Medical Imaging, Inc. Market 2023-2030 ($M)
25.1.10 Eckert Ziegler Market 2023-2030 ($M)
25.1.11 International Isotopes Inc. Market 2023-2030 ($M)
25.1.12 SHINE Medical Technologies Inc. Market 2023-2030 ($M)
26.MENA Therapeutic Nuclear Medicine Market Analysis and Forecast , By Radionuclide Type Market 2023-2030 ($M)
26.1 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
26.1.1 Radium-223 Market 2023-2030 ($M)
26.1.2 Iodine-131 Market 2023-2030 ($M)
26.1.3 Leutitium-177 Market 2023-2030 ($M)
26.1.4 Yttrium-90 Market 2023-2030 ($M)
26.1.5 Samarium-153 Market 2023-2030 ($M)
26.1.6 Strontium-89 Market 2023-2030 ($M)
26.1.7 Rhenium-188 + Rhenium-186 Market 2023-2030 ($M)
26.1.8 Erbium-169 Market 2023-2030 ($M)
26.1.9 Phosphorus-32 Market 2023-2030 ($M)
26.2 By Radionuclide Type, Market 2023-2030 ($M) - Regional Industry Research
27.MENA Therapeutic Nuclear Medicine Market Analysis and Forecast , By Indication Market 2023-2030 ($M)
27.1 By Indication, Market 2023-2030 ($M) - Regional Industry Research
27.1.1 Prostate Cancer Market 2023-2030 ($M)
27.1.2 Painful Bone Metastases Market 2023-2030 ($M)
27.1.3 Thyroid Cancer Market 2023-2030 ($M)
27.1.4 Neuroblastoma Market 2023-2030 ($M)
27.1.5 Synovitis Market 2023-2030 ($M)
27.1.6 Non-Hodgkins Lymphoma Market 2023-2030 ($M)
27.1.7 Hepatic Metastases Market 2023-2030 ($M)
27.1.8 Brain Tumour Market 2023-2030 ($M)
27.2 By Indication, Market 2023-2030 ($M) - Regional Industry Research
28.MENA Therapeutic Nuclear Medicine Market Analysis and Forecast , By End User Market 2023-2030 ($M)
28.1 By End User, Market 2023-2030 ($M) - Regional Industry Research
28.1.1 Hospitals Market 2023-2030 ($M)
28.1.2 Ambulatory Surgical Centers Market 2023-2030 ($M)
28.1.3 Cancer Research Institutes Market 2023-2030 ($M)
28.2 By End User, Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
2.Canada Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
3.Mexico Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
4.Brazil Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
5.Argentina Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
6.Peru Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
7.Colombia Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
8.Chile Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
9.Rest of South America Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
10.UK Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
11.Germany Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
12.France Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
13.Italy Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
14.Spain Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
15.Rest of Europe Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
16.China Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
17.India Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
18.Japan Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
19.South Korea Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
20.South Africa Therapeutic Nuclear Medicines Sales Market Revenue, 2023-2030 ($M)
21.North America Therapeutic Nuclear Medicines Sales By Application
22.South America Therapeutic Nuclear Medicines Sales By Application
23.Europe Therapeutic Nuclear Medicines Sales By Application
24.APAC Therapeutic Nuclear Medicines Sales By Application
25.MENA Therapeutic Nuclear Medicines Sales By Application